Enlivex Therapeutics (ENLV)
(Delayed Data from NSDQ)
$1.23 USD
-0.06 (-4.65%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.23 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
09/06/2024
Time: -- |
6/2024 | $-0.22 | 0.00% |
Earnings Summary
For their last quarter, Enlivex Therapeutics (ENLV) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.25 per share. This reflects a positive earnings surprise of 12.00%. Look out for ENLV's next earnings release expected on September 06, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year increase of 40.54%.
Earnings History
Price & Consensus
Zacks News for ENLV
New Strong Buy Stocks for November 3rd
ENLV: What are Zacks experts saying now?
Zacks Private Portfolio Services